openPR Logo
Press release

FDA Warning Prompts DePuy Orthopaedics to Halt Sale of Custom Joint Replacements

01-23-2012 02:16 PM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen, LLP reports that Johnson & Johnson’s DePuy Orthopaedics is halting the sale of certain custom joint replacements after receiving a warning from the U.S. Food and Drug Administration.

Los Angeles, CA, January 20, 2012 – Johnson & Johnson’s DePuy Orthopaedics says it will stop selling custom-fitted joint replacement devices after being warned by the U.S. Food and Drug Administration that the products were not in compliance with the organization’s approval guidelines.

In a letter dated December 8, the FDA said that DePuy manufactured 14 types of devices, including hip and knee replacement systems, without obtaining pre-market clearance or proper approval. DePuy argued that the devices in question were custom-made for specific patients and did not require additional approval but the FDA disagreed.

According to the Asbury Park Press, the FDA issued a letter this week warning DePuy that pre-market approval or new 510(k) applications would be required for all custom devices and components the company sold. DePuy has since suspended the sale of all custom devices and says it will also address concerns raised by the FDA over quality issues.

The FDA’s latest warning only adds to the troubles faced by DePuy. The company is currently being sued by a number of patients who claim they were seriously injured by one of the company’s metal hip implants. Mounting consumer complaints lead the company to recall its ASR hip replacement system in 2010. Many patients who received one of the metal hips reported severe pain, swelling, tissue damage, metallosis and other serious side effects.

If you or a loved one has experienced complications after receiving a metal hip implant, you may complete a MedWatch form by visiting www.fda.gov. It’s also recommended that you contact an experienced hip implant injury attorney to discuss your legal rights.

Nadrich & Cohen LLP offers confidential, no-cost consultations to patients across the country who believe they were harmed by a defective hip. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.depuyhipreplacementlawyers.net.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California specializing in handling mass tort actions and representing individuals in cases involving pharmaceutical companies and medical device manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling DePuy and Zimmer hip claims, Nadrich & Cohen LLP is also investigating cases involving Accutane, Actos, Avandia, Fosamax, Paxil, Zoloft, Vaginal Mesh, Wright Conserve Hips, Yaz, Yasmin, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan.

The time you have to file an injury claim is limited, so it’s important to act as quickly as possible to protect your rights. Call 1-800-722-0765 today to speak with a qualified personal injury expert or visit www.personalinjurylawcal.com.

Nadrich & Cohen LLP is a national law firm specializing in representing individuals who have been injured by defective medical devices, harmful prescription drugs, faulty products, car accidents, motorcycle accidents and dog bites. For more information, visit www.PersonalInjuryLawCal.com.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FDA Warning Prompts DePuy Orthopaedics to Halt Sale of Custom Joint Replacements here

News-ID: 207998 • Views:

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the

All 5 Releases


More Releases for DePuy

Global Orthopedic Prosthetics Market Research Report Explores the Trade Trends f …
Global Orthopedic Prosthetics Market Research Report 2021-2025 published by reportsweb shares a versatile overview of the market scenario including the present as well as the future state of the market. The report delivers content on emerging trends, and market dynamics with respect to drivers, opportunities, and challenges. The report throws light on the assessment of previous growth developments. It highlights market overview, key players profiling, key developments, suppliers of raw
Orthopedic Trauma Fixation Devices Market Outlook to 2025: DePuy Synthes Compani …
According to Research For Markets, The Orthopedic Trauma Fixation Devices Market is a complete background analysis of Healthcare industry, which includes an assessment of the parental market. The Report contains all the Market shares and approaches of key players in Orthopedic Trauma Fixation Devices market. The report consists of all the detailed profiles for the Orthopedic Trauma Fixation Devices market’s major manufacturers and importers who are influencing the market. It is
DePuy Synthes dominates the global spinal surgical devices market.
Global Spinal Surgical Devices market is set to surpass US$ 12.5 Billion by 2025. Market growth can be attributed to factors such as increasing preference for Minimally Invasive Spinal Surgery (MISS) procedures, increasing geriatric and obese population with increasing number of spine deformities and technological advancements in spine surgery devices are the key factors fuelling the growth of the spinal surgical devices market. Spinal Surgical Devices Market: Country–wise Outlook United States is expected
Cervical Fusion Market Synopsis 2018 To 2023| Risen With DePuy Spine, DePuy Spin …
Market Scenario: The neck pain occurs due to degenerative changes in spinal discs in the cervical region of the spine. Discectomy is the most common surgical procedures for problems related to the cervical vertebral column. The surgical procedure involves the removal of the vertebral disc. The cervical spinal fusion also known as arthrodesis is a surgery to connect selected bones in the cervical vertebral column of the spine below the neck. Factors
Status Conference Set in DePuy ASR Hip Multidistrict Litigation
A status conference in the pending DePuy ASR hip implant MDL has been scheduled for later this month. Nadrich & Cohen LLP is currently offering free case evaluations to patients in all 50 states who believe they were injured by a defective metal hip. Los Angeles, CA, January 13, 2011 – Nadrich & Cohen LLP reports that a status conference has been scheduled for January 23, 2012 in the pending DePuy
First Hearing Held in DePuy Hip Replacement Federal Lawsuits
The federal court overseeing the DePuy hip replacement lawsuits pending against DePuy Orthopaedics held a status conference yesterday. Lawyers from the consumer injury law firm Bernstein Liebhard LLP and a number of other law firms which have also filed cases on behalf of those suffering injuries from the recalled DePuy hip implants attended the hearing. The hearing came shortly after the federal lawsuits concerning DePuy hip replacements were consolidated by